Free Trial

The Pennant Group (NASDAQ:PNTG) Receives "Overweight" Rating from Stephens

The Pennant Group logo with Medical background

Key Points

  • Stephens has reiterated an "overweight" rating for The Pennant Group (NASDAQ:PNTG) with a target price of $40.00, indicating a potential upside of 62.01% from its current price.
  • Other analysts have mixed views: Wells Fargo reduced their target to $29.00 with an "equal weight" rating, while Wall Street Zen upgraded it to a "buy".
  • The Pennant Group has a market capitalization of $853.34 million and institutional investors own 85.88% of its stock.
  • MarketBeat previews the top five stocks to own by November 1st.

Stephens restated their overweight rating on shares of The Pennant Group (NASDAQ:PNTG - Free Report) in a research report report published on Thursday morning,Benzinga reports. They currently have a $40.00 target price on the stock.

A number of other research firms have also weighed in on PNTG. Wells Fargo & Company lowered their target price on shares of The Pennant Group from $31.00 to $29.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Wall Street Zen upgraded shares of The Pennant Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Finally, Truist Financial lowered their target price on shares of The Pennant Group from $32.00 to $28.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $34.40.

View Our Latest Analysis on The Pennant Group

The Pennant Group Trading Up 1.0%

Shares of The Pennant Group stock traded up $0.25 during trading on Thursday, hitting $24.76. The company's stock had a trading volume of 153,491 shares, compared to its average volume of 255,825. The stock has a market cap of $855.71 million, a price-to-earnings ratio of 31.77, a price-to-earnings-growth ratio of 2.00 and a beta of 1.31. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.21 and a quick ratio of 1.21. The Pennant Group has a 52 week low of $21.18 and a 52 week high of $37.13. The stock has a 50-day moving average price of $24.44 and a two-hundred day moving average price of $25.72.

Institutional Investors Weigh In On The Pennant Group

A number of large investors have recently added to or reduced their stakes in PNTG. NBC Securities Inc. bought a new stake in shares of The Pennant Group during the 1st quarter valued at about $25,000. Turtle Creek Asset Management Inc. raised its holdings in The Pennant Group by 150.0% in the fourth quarter. Turtle Creek Asset Management Inc. now owns 2,500 shares of the company's stock worth $66,000 after buying an additional 1,500 shares during the last quarter. Tower Research Capital LLC TRC raised its holdings in The Pennant Group by 161.6% in the second quarter. Tower Research Capital LLC TRC now owns 3,987 shares of the company's stock worth $119,000 after buying an additional 2,463 shares during the last quarter. State of Wyoming raised its holdings in shares of The Pennant Group by 41.3% during the first quarter. State of Wyoming now owns 6,170 shares of the company's stock valued at $155,000 after purchasing an additional 1,803 shares during the last quarter. Finally, ProShare Advisors LLC purchased a new position in shares of The Pennant Group during the second quarter valued at approximately $207,000. Institutional investors own 85.88% of the company's stock.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Stories

Analyst Recommendations for The Pennant Group (NASDAQ:PNTG)

Should You Invest $1,000 in The Pennant Group Right Now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.